Why the study?
Does 6% hydroxyethyl starch compared to 25% albumin affect lung water accumulation in patients undergoing cardiopulmonary bypass?
Does 6% hydroxyethyl starch compared to 25% albumin affect lung water accumulation in patients undergoing cardiopulmonary bypass?
6% hydroxyethyl starch may be a cost-effective alternative to 25% albumin for cardiopulmonary pump prime solutions without persistent adverse effects on extravascular lung water.
Answers are grounded in this paper and cite their sources.
Transient post-bypass EVLW rise resolves by ICU; supports hydroxyethyl starch as potential albumin alternative but remains hypothesis-generating.
Six per cent hydroxyethyl starch was compared prospectively with 25% albumin as the oncotic component of cardiopulmonary pump prime solutions. Oncotic pressure of the pump prime solution was measured, and serum oncotic pressure (OP) values were recorded at designated times during the perioperative period. Changes in these values were compared with alterations in extravascular lung water (EVLW), the serum oncotic pressure-pulmonary artery occluded pressure gradient and the alveolar-arterial difference in oxygen tension [D(A-a)O2] before and immediately after bypass and in the surgical intensive care unit after operation. A significant increase in EVLW was associated with a decrease in serum OP and an increase in D(A-a)O2 immediately after bypass. However, EVLW values had returned to baseline by time of determination in the surgical intensive care unit. Cost savings may be realized by the use of hydroxyethyl starch in this setting if average wholesale price data are representative of costs throughout the country.
No takes yet. Share an insight, caveat, or question.
Philip D. Lumb (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: